+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Iron Deficiency Anemia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767609
  • Report
  • April 2019
  • Region: Global
  • 393 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • Allergan Plc
  • AMAG Pharmaceuticals Inc
  • Daiichi Sankyo Co Ltd
  • Galenica Ltd
  • ICON Plc
  • Pharmacosmos AS
  • MORE
The global clinical trial report- “2019 Iron Deficiency Anemia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Iron Deficiency Anemia. It presents in-depth analysis of Iron Deficiency Anemia clinical trials across markets and companies. The research work is for providing complete understanding into trends in Iron Deficiency Anemia.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Iron Deficiency Anemia clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Iron Deficiency Anemia

The research work is prepared through extensive and continuous research on Iron Deficiency Anemia trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Iron Deficiency Anemia patients are identified
  • The report includes panorama of Iron Deficiency Anemia clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Iron Deficiency Anemia clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Allergan Plc
  • AMAG Pharmaceuticals Inc
  • Daiichi Sankyo Co Ltd
  • Galenica Ltd
  • ICON Plc
  • Pharmacosmos AS
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Iron Deficiency Anemia Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Iron Deficiency Anemia Clinical Trials by Region
2.2.2 Average Enrollment of Iron Deficiency Anemia Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Iron Deficiency Anemia Treatment, 2019

3. Region wise Iron Deficiency Anemia Clinical Trials
3.1 Asia Pacific Iron Deficiency Anemia Clinical Trials by Country
3.2 Europe Iron Deficiency Anemia Clinical Trials by Country
3.3 North America Iron Deficiency Anemia Clinical Trials by Country
3.4 Middle East and Africa Iron Deficiency Anemia Clinical Trials by Country
3.5 South and Central America Iron Deficiency Anemia Clinical Trials by Country

4. Iron Deficiency Anemia Clinical Trial Trends
4.1 Start Year wise Iron Deficiency Anemia Clinical Trials
4.2 Phase wise Iron Deficiency Anemia Clinical Trials
4.3 Trial Status wise Iron Deficiency Anemia Clinical Trials
4.4 Trial Type wise Iron Deficiency Anemia Clinical Trials

5. Iron Deficiency Anemia Average Enrollment Trends
5.1 Average Enrollment in Iron Deficiency Anemia Trials by Year
5.2 Average Enrollment in Iron Deficiency Anemia Trials by Phase
5.3 Average Enrollment in Iron Deficiency Anemia Trials by Status
5.4 Average Enrollment in Iron Deficiency Anemia Trials by Type of Trial

6. Companies Participating in Iron Deficiency Anemia Clinical Trials
6.1 Iron Deficiency Anemia Trials by Sponsor Type
6.2 Iron Deficiency Anemia Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Iron Deficiency Anemia Trials- Phase 1
7.2 Iron Deficiency Anemia Trials- Phase 2
7.3 Iron Deficiency Anemia Trials- Phase 3
7.4 Iron Deficiency Anemia Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Iron Deficiency Anemia Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Iron Deficiency Anemia Clinical Trials and Enrolment
Figure 5: Europe - Country wise Iron Deficiency Anemia Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Iron Deficiency Anemia Clinical Trials and Enrolment
Figure 7: North America - Country wise Iron Deficiency Anemia Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Iron Deficiency Anemia Clinical Trials and Enrolment
Figure 9: Iron Deficiency Anemia Clinical Trials by Phase
Figure 10: Iron Deficiency Anemia Clinical Trials by Trial Status
Figure 11: Iron Deficiency Anemia Clinical Trials by Type
Figure 12: Iron Deficiency Anemia Clinical Trials by Sponsor Type
Figure 13: Iron Deficiency Anemia Clinical Trials by Leading Sponsors
Figure 14: Iron Deficiency Anemia Average Enrollment by Phase
Figure 15: Iron Deficiency Anemia Average Enrollment by Trial Status
Figure 16: Iron Deficiency Anemia Average Enrollment by Type
Figure 17: Iron Deficiency Anemia- Average Enrolment by Type of Sponsors
Figure 18: Iron Deficiency Anemia- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Iron Deficiency Anemia Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Iron Deficiency Anemia Clinical Trials and Enrolment
Table 5: Europe - Country wise Iron Deficiency Anemia Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Iron Deficiency Anemia Clinical Trials and Enrolment
Table 7: North America - Country wise Iron Deficiency Anemia Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Iron Deficiency Anemia Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Iron Deficiency Anemia Average Enrollment by Phase
Table 15: Iron Deficiency Anemia Average Enrollment by Trial Status
Table 16: Iron Deficiency Anemia Average Enrollment by Type
Table 17: Iron Deficiency Anemia- Average Enrolment by Type of Sponsors
Table 18: Iron Deficiency Anemia- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Allergan Plc
  • AMAG Pharmaceuticals Inc
  • Daiichi Sankyo Co Ltd
  • Galenica Ltd
  • ICON Plc
  • International Centre for Diarrhoeal Disease Research Bangladesh
  • Pharmacosmos AS
  • Pierre Fabre Foundation
  • Rockwell Medical Inc
  • Shield Therapeutics Plc
Note: Product cover images may vary from those shown
Adroll
adroll